Celularity Inc (CELU) stock
CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.48−0.09 (-15.41%)
Close on Nov 18, 2026Market cap $15.68MP/E –Yield –
Celularity free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Celularity's free cash flow for the twelve months ending Dec 31, 2024 was -$6.56M. For fiscal 2024 it was -$6.56M. The highest annual figure on record is -$6.56M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$6.56M | – |
| FY2023 | Dec 31, 2023 | -$39.73M | – |
| FY2022 | Dec 31, 2022 | -$143.11M | – |
| FY2021 | Dec 31, 2021 | -$116.30M | – |
| FY2020 | Dec 31, 2020 | -$91.03M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $1.50M | – |
| Q3 FY2024 | Sep 30, 2024 | -$144.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.48M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.44M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.92M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.55M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.06M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.20M | – |
| Q4 FY2022 | Dec 31, 2022 | -$30.36M | – |
| Q3 FY2022 | Sep 30, 2022 | -$39.28M | – |
| Q2 FY2022 | Jun 30, 2022 | -$37.76M | – |
| Q1 FY2022 | Mar 31, 2022 | -$35.71M | – |
| Q4 FY2021 | Dec 31, 2021 | -$34.35M | – |
| Q3 FY2021 | Sep 30, 2021 | -$35.88M | – |
| Q2 FY2021 | Jun 30, 2021 | -$19.51M | – |
| Q1 FY2021 | Mar 31, 2021 | -$26.56M | – |
| Q4 FY2020 | Dec 31, 2020 | -$26.20M | – |
See a number that looks wrong?